<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/64BC5E73-972F-41E1-A12C-D97DC9BDFB93"><gtr:id>64BC5E73-972F-41E1-A12C-D97DC9BDFB93</gtr:id><gtr:name>MRC Clinical Sciences Centre</gtr:name><gtr:address><gtr:line1>Faculty of Medicine Imperial College</gtr:line1><gtr:line2>London Hammersmith Campus</gtr:line2><gtr:line3>Du Cane Road</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>W12 0NN</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/64BC5E73-972F-41E1-A12C-D97DC9BDFB93"><gtr:id>64BC5E73-972F-41E1-A12C-D97DC9BDFB93</gtr:id><gtr:name>MRC Clinical Sciences Centre</gtr:name><gtr:address><gtr:line1>Faculty of Medicine Imperial College</gtr:line1><gtr:line2>London Hammersmith Campus</gtr:line2><gtr:line3>Du Cane Road</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>W12 0NN</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/9C50CB6E-4A48-477D-9BC8-908C1C04CBB9"><gtr:id>9C50CB6E-4A48-477D-9BC8-908C1C04CBB9</gtr:id><gtr:firstName>Santiago</gtr:firstName><gtr:surname>Vernia</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_UP_1102%2F18"><gtr:id>706C7AB0-1933-4831-823E-64DA9B6AD400</gtr:id><gtr:title>Metabolism and Gene Regulation</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_UP_1102/18</gtr:grantReference><gtr:abstractText>The rising prevalence of type 2 diabetes (T2D) constitutes a major health problem that strongly correlates with an elevated incidence of obesity. It is estimated that almost 500 million people will suffer from this disease worldwide in 2030.
The crosstalk between tissues that regulate metabolic homeostasis in response to environmental and nutritional demands is impaired in T2D patients. 
The liver has a pivotal role in this communication, controlling the metabolism of carbohydrates and lipids and the secretion of bioactive molecules. Characterisation of these molecules is critical to understand the mechanisms leading to insulin resistance and the complications associated with T2D, and to generate more selective and efficacious therapies. 
We will use both computational and experimental approaches to identify the molecules involved in the crosstalk between hepatocytes and other cellular populations such as adipocytes, beta-cells, immune cells or neurons, in health and disease. The characterisation of these molecules will provide valuable information about the hepatic and systemic metabolic homeostasis and may have potential diagnostic and therapeutic utility in metabolic diseases such as T2D and obesity.</gtr:abstractText><gtr:technicalSummary>The liver has a pivotal role controlling the metabolism of carbohydrates and lipids and the secretion of bioactive molecules, including pro- and anti-inflammatory hepatokines that are involved in multi-organ crosstalk. Characterisation of small molecules and hepatokines involved in this communication is critical to understand the molecular mechanisms leading to insulin resistance, the decline in ?-cell function, inflammation and cardiovascular complications associated with Type 2 diabetes (T2D) and obesity.
However, the complexity of these metabolic diseases, that involve interactions between tissues such as the liver, adipose tissue, immune system and brain, the action of hormones and the network of signalling pathways linked to insulin, such as mTORC or the stress-activated cJUN N-terminal Kinase (JNK), has been difficult to decipher. 
JNK pathway is activated by consuming a high fat diet, and preventing this activation by tissue-specific ablation of JNK in mouse models inhibits the development of obesity, inflammation and insulin resistance. Therefore, JNK is critical in the crosstalk between metabolic organs and the immune response in the course of metabolic disorders, although its downstream effectors are largely unknown. 
We use mice with genetic and pharmacological inactivation of JNK in hepatocytes, Tandem Mass Tag (TMT-MS) proteomics and Next Generation Sequencing (RNAseq) as a viable strategy to identify new hepatokines involved in metabolic regulation. 
Using a TMT-MS screening we identified a group of JNK-regulated hepatokines, including proteins involved in immune response such as complement proteins or previously characterised metabolic regulators (such as RBP4), confirming the potential of this approach to identify metabolic regulators. In addition, we identified other secreted proteins without a known role in metabolic regulation.
We aim to characterise interesting candidates identified in this approach. We will use adeno-associated viral vectors, CRISPR/CAS9-based systems and mouse models of obesity and insulin resistance to study the role of these hepatokines in the multi-organ crosstalk and metabolic regulation.
The short-term goal of this proposal is to identify and characterise JNK-regulated hepatokines that may be involved in diet-induced inflammation and insulin resistance. The long-term goal of this proposal is to characterise novel mediators of the communication between organ systems that may be involved in diet-induced metabolic dysfunction, to uncover new diagnostic and therapeutic targets in metabolic pathologies.</gtr:technicalSummary><gtr:fund><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2016-02-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>474403</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Invited talk</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>5FCF23BB-4F1A-4DFC-94B8-35148BE758E8</gtr:id><gtr:impact>Invited talk in the London Institute of Medical Sciences</gtr:impact><gtr:outcomeId>5898ad02ce3df4.68640838</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited talk for non-scientific MRC employees</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>8CC335E8-537A-4017-9B29-1B6E2E7E94D7</gtr:id><gtr:impact>Invited talk for non-scientific MRC employees to discuss about our research on genes involved in metabolic homeostasis and the effect of consuming a high fat diet</gtr:impact><gtr:outcomeId>5898ad663513b2.34550080</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited in the London Institute of Medical Sciences</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>E1F71556-02C1-4096-A438-E9582CD8B0C1</gtr:id><gtr:impact>Invited talk for new PhD students</gtr:impact><gtr:outcomeId>5898ae09251c29.59597508</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>2000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>President's PhD Scholarship awarded to Helen Paterson</gtr:description><gtr:end>2019-10-02</gtr:end><gtr:fundingOrg>Imperial College London</gtr:fundingOrg><gtr:id>CCED47D9-EEF8-4A57-823C-0CC58C3B590E</gtr:id><gtr:outcomeId>589a0b7857e7a8.90750405</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>Deep RNA seq of control vs. insulin resistant mouse liver under different nutritional states (fed ad libitum or fasted).</gtr:description><gtr:id>26259865-F693-4C83-AA89-E90E8E0528EB</gtr:id><gtr:impact>The depth of these sequences will allow the identification of splicing variants involved in metabolic control in health and disease.</gtr:impact><gtr:outcomeId>589db90c0c9185.84170764</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>RNAseq liver</gtr:title><gtr:type>Database/Collection of data</gtr:type></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Development of Adeno-associated viruses with CRISPRi and CRISPRa technology</gtr:description><gtr:id>12DF275E-42C8-4A2A-9F56-8DB32A046B1D</gtr:id><gtr:impact>These viruses will promote the 3Rs rule</gtr:impact><gtr:outcomeId>589db9cb4ae000.33286324</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Development of Adeno-associated viruses with CRISPRi and CRISPRa technology</gtr:title><gtr:type>Data handling &amp; control</gtr:type></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have generated new plasmids to produce AAVs and express specific genes, shRNAs in the liver.</gtr:description><gtr:id>051CD9AC-1948-4C92-BC06-525745F2A27F</gtr:id><gtr:impact>The use of AAV viruses significantly reduces the number of mice used, and provides a simple tool to modulate the expression of specific genes in tissues such as the liver.</gtr:impact><gtr:outcomeId>5898a8aabe24e1.13169608</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Adeno associated virus vectors (AAV)</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>These cells constitutively express specific CAS9 proteins.</gtr:description><gtr:id>F2358155-2D0C-4DAD-9D93-47A3892C3E6F</gtr:id><gtr:impact>These cells can be used to test the efficiency of specific gRNAs in CRISPR-based approaches, and can be useful to asses the effect of specific genes in adipogenesis.</gtr:impact><gtr:outcomeId>5898a95677f5a6.08359624</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>3T3 cells expressing spCAS9, saCAS9, dead-saCAS9 and dead-saCAS9-VP64</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>E7BF4148-CC9A-4DE8-9B27-4FBAE7ADC3F6</gtr:id><gtr:title>An alternative splicing program promotes adipose tissue thermogenesis.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fda0d77393471ec5056cedb209851bc"><gtr:id>0fda0d77393471ec5056cedb209851bc</gtr:id><gtr:otherNames>Vernia S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>587c9f52bbef97.98754922</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EB36C128-FC8C-4BF0-BE69-49D7F260ECA3</gtr:id><gtr:title>Lafora bodies and neurological defects in malin-deficient mice correlate with impaired autophagy.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8c7d6b3c93f52369543ca22dbe35715"><gtr:id>d8c7d6b3c93f52369543ca22dbe35715</gtr:id><gtr:otherNames>Criado O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>587c9f54b55183.34996059</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4BC0E25B-6377-4A5E-9FE2-4D42D499BAED</gtr:id><gtr:title>A rare missense mutation in a type 2 diabetes patient decreases the transcriptional activity of human sterol regulatory element binding protein-1.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fda0d77393471ec5056cedb209851bc"><gtr:id>0fda0d77393471ec5056cedb209851bc</gtr:id><gtr:otherNames>Vernia S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>587c9f570bc398.82666622</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6903E9B2-E6F4-4803-97E8-E1EFA18DE1F9</gtr:id><gtr:title>Differential sensitivity of rat hepatocyte CYP isoforms to self-generated nitric oxide.</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fda0d77393471ec5056cedb209851bc"><gtr:id>0fda0d77393471ec5056cedb209851bc</gtr:id><gtr:otherNames>Vernia S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2001-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn><gtr:outcomeId>587c9f57557685.47938667</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>25634BB9-CD0A-4751-9EA9-86BF3718F350</gtr:id><gtr:title>Excitatory transmission onto AgRP neurons is regulated by cJun NH2-terminal kinase 3 in response to metabolic stress.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fda0d77393471ec5056cedb209851bc"><gtr:id>0fda0d77393471ec5056cedb209851bc</gtr:id><gtr:otherNames>Vernia S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>587c9f53636b11.03290951</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B499E18-73E3-486A-9B7C-01422BDD8AEA</gtr:id><gtr:title>A new PCSK9 gene promoter variant affects gene expression and causes autosomal dominant hypercholesterolemia.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/371c6d1ae71b2c8e474b10d7d0a5cf92"><gtr:id>371c6d1ae71b2c8e474b10d7d0a5cf92</gtr:id><gtr:otherNames>Blesa S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>587c9f56c710e1.92547135</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC1B8E3A-43CA-4829-814E-6C384B56E8C1</gtr:id><gtr:title>Identification of a novel Pfkfb1 mRNA variant in rat fetal liver.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2027ab29a6ed5ad8b5ade6ad1538cbde"><gtr:id>2027ab29a6ed5ad8b5ade6ad1538cbde</gtr:id><gtr:otherNames>Cosin-Roger J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn><gtr:outcomeId>587c9f545d7898.04808877</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D777BE6-089B-46B2-9E50-2AB4BAAA1A10</gtr:id><gtr:title>Fibroblast Growth Factor 21 Mediates Glycemic Regulation by Hepatic JNK.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fda0d77393471ec5056cedb209851bc"><gtr:id>0fda0d77393471ec5056cedb209851bc</gtr:id><gtr:otherNames>Vernia S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>587c9f533fd6a0.64589246</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EE8E9F5D-1230-43D7-83C0-74EDECBE87EB</gtr:id><gtr:title>Malin knockout mice support a primary role of autophagy in the pathogenesis of Lafora disease.</gtr:title><gtr:parentPublicationTitle>Autophagy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6e5d450f9e9b1b53949e4329bd64e48a"><gtr:id>6e5d450f9e9b1b53949e4329bd64e48a</gtr:id><gtr:otherNames>Knecht E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1554-8627</gtr:issn><gtr:outcomeId>587c9f548bf1b3.89307001</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>302CFBF9-DF63-4878-B62B-F9B136C0A0ED</gtr:id><gtr:title>Adipose tissue mTORC2 regulates ChREBP-driven de novo lipogenesis and hepatic glucose metabolism.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b37d1950beadde9137ccd8e4f48ed375"><gtr:id>b37d1950beadde9137ccd8e4f48ed375</gtr:id><gtr:otherNames>Tang Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>587c9f530e8ed8.70343497</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F573964D-AD5F-462C-B0C6-F4498DA58B7E</gtr:id><gtr:title>A PTG variant contributes to a milder phenotype in Lafora disease.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c3da85eec71df5b14685b7376e29fd4c"><gtr:id>c3da85eec71df5b14685b7376e29fd4c</gtr:id><gtr:otherNames>Guerrero R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>587c9f5521f2c2.10768762</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CAFEAA45-0B51-46CF-92C7-9BA0C958D1DC</gtr:id><gtr:title>Involvement of peroxynitrite on the early loss of p450 in short-term hepatocyte cultures.</gtr:title><gtr:parentPublicationTitle>Advances in experimental medicine and biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fda0d77393471ec5056cedb209851bc"><gtr:id>0fda0d77393471ec5056cedb209851bc</gtr:id><gtr:otherNames>Vernia S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2001-01-01</gtr:date><gtr:issn>0065-2598</gtr:issn><gtr:outcomeId>587c9f572e7d23.12667156</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA551B2C-B11A-4F63-830F-5B1BEDE0D8CA</gtr:id><gtr:title>Lafora disease E3-ubiquitin ligase malin is related to TRIM32 at both the phylogenetic and functional level.</gtr:title><gtr:parentPublicationTitle>BMC evolutionary biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40d7317dfa800ef80d658134632ad5bd"><gtr:id>40d7317dfa800ef80d658134632ad5bd</gtr:id><gtr:otherNames>Rom?-Mateo C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1471-2148</gtr:issn><gtr:outcomeId>587c9f54de5874.29467820</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D880B702-2C69-4532-B606-A50BDCC6ECF8</gtr:id><gtr:title>Inactivation of nuclear GSK3? by Ser(389) phosphorylation promotes lymphocyte fitness during DNA double-strand break response.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d93ef002fc99968595b03a83404630e"><gtr:id>9d93ef002fc99968595b03a83404630e</gtr:id><gtr:otherNames>Thornton TM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>587c9f538c0034.50174492</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DAE58134-A833-4AA5-BD67-45AAAE9BA1E9</gtr:id><gtr:title>Sumoylation of AMPK?2 subunit enhances AMP-activated protein kinase activity.</gtr:title><gtr:parentPublicationTitle>Molecular biology of the cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f685ff0e513e645aa6769398cc32651"><gtr:id>1f685ff0e513e645aa6769398cc32651</gtr:id><gtr:otherNames>Rubio T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1059-1524</gtr:issn><gtr:outcomeId>587c9f54382e16.63970637</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9475A226-775B-4A36-AA1D-EC43F383E041</gtr:id><gtr:title>The PPARa-FGF21 hormone axis contributes to metabolic regulation by the hepatic JNK signaling pathway.</gtr:title><gtr:parentPublicationTitle>Cell metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fda0d77393471ec5056cedb209851bc"><gtr:id>0fda0d77393471ec5056cedb209851bc</gtr:id><gtr:otherNames>Vernia S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1550-4131</gtr:issn><gtr:outcomeId>587c9f53cfb106.71844301</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>00C27DEC-C6E8-442B-9EBD-9B673549126E</gtr:id><gtr:title>Diet-induced obesity mediated by the JNK/DIO2 signal transduction pathway.</gtr:title><gtr:parentPublicationTitle>Genes &amp; development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fda0d77393471ec5056cedb209851bc"><gtr:id>0fda0d77393471ec5056cedb209851bc</gtr:id><gtr:otherNames>Vernia S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0890-9369</gtr:issn><gtr:outcomeId>587c9f53f2b002.51049372</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>321C053B-FEF5-4979-B104-90A265092EF4</gtr:id><gtr:title>Increased endoplasmic reticulum stress and decreased proteasomal function in lafora disease models lacking the phosphatase laforin.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fda0d77393471ec5056cedb209851bc"><gtr:id>0fda0d77393471ec5056cedb209851bc</gtr:id><gtr:otherNames>Vernia S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>587c9f56552cf5.62667146</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DED4AF33-DAEB-4C5C-8DBA-DD9DF154294D</gtr:id><gtr:title>Selective role of sterol regulatory element binding protein isoforms in aggregated LDL-induced vascular low density lipoprotein receptor-related protein-1 expression.</gtr:title><gtr:parentPublicationTitle>Atherosclerosis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e18665e0c5b8d5f55532e7f98bad51bd"><gtr:id>e18665e0c5b8d5f55532e7f98bad51bd</gtr:id><gtr:otherNames>Costales P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9150</gtr:issn><gtr:outcomeId>587c9f55d409d8.98019281</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50C92A8F-1888-40C2-9AA1-8207AB868D68</gtr:id><gtr:title>AMP-activated protein kinase phosphorylates R5/PTG, the glycogen targeting subunit of the R5/PTG-protein phosphatase 1 holoenzyme, and accelerates its down-regulation by the laforin-malin complex.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fda0d77393471ec5056cedb209851bc"><gtr:id>0fda0d77393471ec5056cedb209851bc</gtr:id><gtr:otherNames>Vernia S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>587c9f567fc3e6.10223808</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA15FD96-7855-4A46-9827-2D7D521A6972</gtr:id><gtr:title>Hyper- and hypo- nutrition studies of the hepatic transcriptome and epigenome suggest that PPARa regulates anaerobic glycolysis.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f139a5bfe0275294b89c699bf625f45"><gtr:id>6f139a5bfe0275294b89c699bf625f45</gtr:id><gtr:otherNames>Soltis AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5a79c919629118.35863699</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13472DCB-E650-4096-AE24-50655AB7AD3D</gtr:id><gtr:title>Lafora progressive myoclonus epilepsy: NHLRC1 mutations affect glycogen metabolism.</gtr:title><gtr:parentPublicationTitle>Journal of molecular medicine (Berlin, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8a2ecae6bb77a2ec5ad72b9d466f948"><gtr:id>f8a2ecae6bb77a2ec5ad72b9d466f948</gtr:id><gtr:otherNames>Couarch P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0946-2716</gtr:issn><gtr:outcomeId>587c9f554dab62.93776780</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>320B5563-C028-49C9-AA96-6E1E4AA927C4</gtr:id><gtr:title>Impaired autophagy in Lafora disease.</gtr:title><gtr:parentPublicationTitle>Autophagy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6e5d450f9e9b1b53949e4329bd64e48a"><gtr:id>6e5d450f9e9b1b53949e4329bd64e48a</gtr:id><gtr:otherNames>Knecht E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1554-8627</gtr:issn><gtr:outcomeId>587c9f56058bc1.94130982</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF2BC4BB-01FF-4668-86A7-CF3DC6CF3524</gtr:id><gtr:title>Laforin, the most common protein mutated in Lafora disease, regulates autophagy.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15e3e4e38f7a1ac35eec0bad830b2514"><gtr:id>15e3e4e38f7a1ac35eec0bad830b2514</gtr:id><gtr:otherNames>Aguado C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>587c9f56310eb9.88039400</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0308C5F5-99C5-464F-B28E-B3D8BA7CEB23</gtr:id><gtr:title>Laforin, a dual specificity phosphatase involved in Lafora disease, regulates insulin response and whole-body energy balance in mice.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fda0d77393471ec5056cedb209851bc"><gtr:id>0fda0d77393471ec5056cedb209851bc</gtr:id><gtr:otherNames>Vernia S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>587c9f558d2e60.23569406</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_UP_1102/18</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>160D22D0-5677-4513-A0AC-7F3526B7F336</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Metabolic and Endocrine</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>